| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
N/A |
| Shares
Out: |
19,300,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$57.98 - $57.98 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Godshall Douglas Evan |
President & Chief Exec Officer |
• • – |
2016-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,500 |
86,335 |
|
- |
|
| Leadley Katrin |
Chief Medical Officer |
• – – |
2016-02-24 |
4 |
AS |
$32.38 |
$28,333 |
D/D |
(875) |
0 |
|
- |
|
| Godshall Douglas Evan |
President & Chief Exec Officer |
• • – |
2016-02-24 |
4 |
AS |
$32.35 |
$37,300 |
D/D |
(1,153) |
80,835 |
|
- |
|
| Schuermann James |
SVP, Sales & Marketing |
• – – |
2016-02-24 |
4 |
AS |
$32.23 |
$9,250 |
D/D |
(287) |
12,932 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2016-02-24 |
4 |
AS |
$32.41 |
$6,644 |
D/D |
(205) |
11,636 |
|
- |
|
| Knopf Lawrence J |
General Counsel |
• – – |
2016-02-24 |
4 |
AS |
$32.27 |
$9,261 |
D/D |
(287) |
16,831 |
|
- |
|
| Mcaree Peter F |
SVP, CFO and Treasurer |
• – – |
2016-02-24 |
4 |
AS |
$32.38 |
$14,182 |
D/D |
(438) |
15,183 |
|
- |
|
| Strong Mark |
Senior VP, R&D and Quality |
• – – |
2016-02-24 |
4 |
AS |
$32.34 |
$24,255 |
D/D |
(750) |
2,757 |
|
- |
|
| Leadley Katrin |
Chief Medical Officer |
• – – |
2016-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
875 |
875 |
|
- |
|
| Godshall Douglas Evan |
President & Chief Exec Officer |
• • – |
2016-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,438 |
81,988 |
|
- |
|
| Schuermann James |
SVP, Sales & Marketing |
• – – |
2016-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
875 |
13,219 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2016-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
11,841 |
|
- |
|
| Knopf Lawrence J |
General Counsel |
• – – |
2016-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
875 |
17,118 |
|
- |
|
| Mcaree Peter F |
SVP, CFO and Treasurer |
• – – |
2016-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
875 |
15,621 |
|
- |
|
| Strong Mark |
Senior VP, R&D and Quality |
• – – |
2016-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
3,507 |
|
- |
|
| Knopf Lawrence J |
General Counsel |
• – – |
2016-02-08 |
4 |
AS |
$34.76 |
$20,729 |
D/D |
(568) |
16,243 |
|
- |
|
| Godshall Douglas Evan |
President & Chief Exec Officer |
• • – |
2016-02-08 |
4 |
AS |
$35.04 |
$65,700 |
D/D |
(1,796) |
78,550 |
|
- |
|
| Schuermann James |
SVP, Sales & Marketing |
• – – |
2016-02-08 |
4 |
AS |
$35.07 |
$23,789 |
D/D |
(647) |
12,344 |
|
- |
|
| Mcaree Peter F |
SVP, CFO and Treasurer |
• – – |
2016-02-08 |
4 |
AS |
$35.18 |
$25,792 |
D/D |
(700) |
14,746 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2016-02-08 |
4 |
AS |
$34.76 |
$20,456 |
D/D |
(560) |
11,091 |
|
- |
|
| Knopf Lawrence J |
General Counsel |
• – – |
2016-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,400 |
16,811 |
|
- |
|
| Godshall Douglas Evan |
President & Chief Exec Officer |
• • – |
2016-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
80,346 |
|
- |
|
| Schuermann James |
SVP, Sales & Marketing |
• – – |
2016-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,600 |
12,991 |
|
- |
|
| Mcaree Peter F |
SVP, CFO and Treasurer |
• – – |
2016-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,400 |
15,446 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2016-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,600 |
11,651 |
|
- |
|
199 Records found
|
|
Page 3 of 8 |
|
|
